Share on Facebook Share on Twitter

Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Vaccine effectiveness over time; Including heterogenous boosters
The document "COVID-19 vaccine surveillance report, Week 4, 27 January 2022" from the UK Health Security Agency has some graphs on vaccine effectiveness against Delta and Omicron over time for different vaccines & booster combinations when measured for symptomatic disease, hospitalization, death, infection, transmission.  (From the Steve Shafer Feb. 1 COVID update)

There are other good data in the report.  For instance, % and amount of antibodies in blood donations in UK by age and month (lowest (9%) in 70+; highest(34%) in  17-20yo).  Pregnancy outcomes.

BNT162b2 = Pfizer;  mRNA-1273 = Moderna
Apparently in the UK, the Moderna booster was the half-dose as in the US.

Notice the fall off of the booster over time versus the original doses over time.

Symptomatic disease.
[Image: VE-symp-Ill-Pfizer.png] 

 [Image: VE-symp-Ill-Moderna.png] 

[Image: VE-hosp-Pfizer.png]
(no Moderna)

Messages In This Thread
Vaccine effectiveness over time; Including heterogenous boosters - by M_T - 02-02-2022, 02:13 PM

Forum Jump:

Users browsing this thread: